These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24012365)
21. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance. Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312 [TBL] [Abstract][Full Text] [Related]
22. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs). Greder LV; Post J; Dutton JR Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297 [TBL] [Abstract][Full Text] [Related]
23. Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds. Ye J; Ge J; Zhang X; Cheng L; Zhang Z; He S; Wang Y; Lin H; Yang W; Liu J; Zhao Y; Deng H Cell Res; 2016 Jan; 26(1):34-45. PubMed ID: 26704449 [TBL] [Abstract][Full Text] [Related]
24. Sodium butyrate promotes generation of human induced pluripotent stem cells through induction of the miR302/367 cluster. Zhang Z; Wu WS Stem Cells Dev; 2013 Aug; 22(16):2268-77. PubMed ID: 23534850 [TBL] [Abstract][Full Text] [Related]
25. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency. Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261 [TBL] [Abstract][Full Text] [Related]
26. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency. Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476 [TBL] [Abstract][Full Text] [Related]
27. Differential regulation of OCT4 targets facilitates reacquisition of pluripotency. Thakurela S; Sindhu C; Yurkovsky E; Riemenschneider C; Smith ZD; Nachman I; Meissner A Nat Commun; 2019 Sep; 10(1):4444. PubMed ID: 31570708 [TBL] [Abstract][Full Text] [Related]
28. Evaluating Reprogramming Efficiency and Pluripotency of the Established Human iPSCS by Pluripotency Markers. Cevallos RR; Hossain ME; Zhang R; Hu K Methods Mol Biol; 2021; 2239():235-249. PubMed ID: 33226623 [TBL] [Abstract][Full Text] [Related]
29. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells. Febbraro F; Chen M; Denham M Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617 [TBL] [Abstract][Full Text] [Related]
30. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Zhu S; Li W; Zhou H; Wei W; Ambasudhan R; Lin T; Kim J; Zhang K; Ding S Cell Stem Cell; 2010 Dec; 7(6):651-5. PubMed ID: 21112560 [No Abstract] [Full Text] [Related]
31. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Soufi A; Garcia MF; Jaroszewicz A; Osman N; Pellegrini M; Zaret KS Cell; 2015 Apr; 161(3):555-568. PubMed ID: 25892221 [TBL] [Abstract][Full Text] [Related]
32. A Versatile In Vivo System to Study Myc in Cell Reprogramming. Senís E; Mosteiro L; Grimm D; Abad M Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296 [TBL] [Abstract][Full Text] [Related]
33. Progress in understanding reprogramming to the induced pluripotent state. Plath K; Lowry WE Nat Rev Genet; 2011 Apr; 12(4):253-65. PubMed ID: 21415849 [TBL] [Abstract][Full Text] [Related]
34. Small-molecule-mediated reprogramming: a silver lining for regenerative medicine. Kim Y; Jeong J; Choi D Exp Mol Med; 2020 Feb; 52(2):213-226. PubMed ID: 32080339 [TBL] [Abstract][Full Text] [Related]
35. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages. Li K; Zhu S; Russ HA; Xu S; Xu T; Zhang Y; Ma T; Hebrok M; Ding S Cell Stem Cell; 2014 Feb; 14(2):228-36. PubMed ID: 24506886 [TBL] [Abstract][Full Text] [Related]
36. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773 [TBL] [Abstract][Full Text] [Related]
37. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4. Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023 [TBL] [Abstract][Full Text] [Related]
38. Advances in reprogramming somatic cells to induced pluripotent stem cells. Patel M; Yang S Stem Cell Rev Rep; 2010 Sep; 6(3):367-80. PubMed ID: 20336395 [TBL] [Abstract][Full Text] [Related]
39. Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming. Choi H; Park HJ; Kim H; Kim J; Lee YK; Kim J Biochem Biophys Res Commun; 2019 Oct; 518(2):253-258. PubMed ID: 31412978 [TBL] [Abstract][Full Text] [Related]
40. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium. Shao Z; Cevallos RR; Hu K Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]